ATE137973T1 - Phospholipide zur behandlung der multiplen sklerose - Google Patents

Phospholipide zur behandlung der multiplen sklerose

Info

Publication number
ATE137973T1
ATE137973T1 AT90810594T AT90810594T ATE137973T1 AT E137973 T1 ATE137973 T1 AT E137973T1 AT 90810594 T AT90810594 T AT 90810594T AT 90810594 T AT90810594 T AT 90810594T AT E137973 T1 ATE137973 T1 AT E137973T1
Authority
AT
Austria
Prior art keywords
phospholipids
treatment
multiple sclerosis
chem
useful
Prior art date
Application number
AT90810594T
Other languages
English (en)
Inventor
William Joseph Houlihan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE137973T1 publication Critical patent/ATE137973T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
AT90810594T 1989-08-10 1990-08-07 Phospholipide zur behandlung der multiplen sklerose ATE137973T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39218789A 1989-08-10 1989-08-10
US42332389A 1989-10-18 1989-10-18
US48957890A 1990-03-07 1990-03-07

Publications (1)

Publication Number Publication Date
ATE137973T1 true ATE137973T1 (de) 1996-06-15

Family

ID=27410008

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90810594T ATE137973T1 (de) 1989-08-10 1990-08-07 Phospholipide zur behandlung der multiplen sklerose

Country Status (9)

Country Link
EP (1) EP0412941B1 (de)
JP (1) JPH075468B2 (de)
KR (1) KR910004196A (de)
AT (1) ATE137973T1 (de)
AU (1) AU629967B2 (de)
DE (1) DE69026991T2 (de)
DK (1) DK0412941T3 (de)
ES (1) ES2086395T3 (de)
GR (1) GR3020597T3 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101523312B1 (ko) * 2013-12-03 2015-05-27 한국원자력연구원 백금족 원소를 포함하는 방사성 요오드 포집 용액 및 이를 이용한 방사성 요오드의 포집 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3530767A1 (de) * 1985-08-28 1987-03-12 Max Planck Gesellschaft Mittel gegen multiple sklerose
US4749696A (en) * 1985-08-30 1988-06-07 Sandoz Pharm. Corp. Hydroxy-[1-substituted carbonyl-2-(or 3-) piperidinyl methoxy]phosphinyloxy]-N,N,N-trialkylalkaneaminium hydroxide inner salt oxides having antitumor activity
IE59778B1 (en) * 1985-12-04 1994-04-06 Max Planck Gesellschaft Medicament with anti-tumour action containing hexadecylphosphocholine

Also Published As

Publication number Publication date
EP0412941A3 (en) 1992-01-02
DE69026991T2 (de) 1997-01-16
KR910004196A (ko) 1991-03-28
JPH0377826A (ja) 1991-04-03
DK0412941T3 (da) 1996-06-24
AU629967B2 (en) 1992-10-15
JPH075468B2 (ja) 1995-01-25
EP0412941A2 (de) 1991-02-13
ES2086395T3 (es) 1996-07-01
GR3020597T3 (en) 1996-10-31
DE69026991D1 (de) 1996-06-20
AU6029090A (en) 1991-02-14
EP0412941B1 (de) 1996-05-15

Similar Documents

Publication Publication Date Title
FI931708A0 (fi) Herbicida substituerade aryl-haloalkylpyrazoler
RU94031102A (ru) Сульфамиды в качестве антагонистов эндотелина и способ лечения соответствующих заболеваний
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2059296T3 (es) Inhibidores de proteasas retrovirales.
DE69324859T2 (de) Verwendung von Lipid-gebundener Glykoaminoglykanen zur Behandlung der rheumatoider Arthritis
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
DK140996A (da) Fremgangsmåde til fremstilling af 2,3,4,5-tetraflour-6-alkyl-benzoesyreforbindelser
DE69334250D1 (de) Verfahren und Intermediate zur Herstellung von retroviralen Proteasehemmern
FI956119A0 (fi) Fenyyliheterosyklejä syklo-oksigenaasi-2-inhibiittoreina
ATE267180T1 (de) Phosphorderivate zur behandlung von aids
DK0604183T3 (da) HIV-protease-inhibitorer anvendelige i behandlingen af AIDS
DE69405919T2 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
EA200000242A1 (ru) Применение фанхинона для лечения болезни альцгеймера
ATE148109T1 (de) Hiv-proteaseinhibitoren und ihre verwendung zur behandlung von aids
DE69913380D1 (de) Zusammensetzung zur behandlung von periodontalen erkrankungen
FI900083A (fi) Nya tetralinderivat.
DE9411754U1 (de) Laser-Ahle zur Behandlung der Osteochondritis deformans
ATE137973T1 (de) Phospholipide zur behandlung der multiplen sklerose
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
NO874404L (no) Fremgangsmaate for fremstilling av acyleringsprodukter av bis (2-imidazolin-2-ylhydrazoner) av 9,10-antracendikarboksaldehyd.